YCMGA
BSX icon

York Capital Management Global Advisors’s Boston Scientific BSX Stock Holding History

York Capital Management Global Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-728,734
Closed -$26.2M – 54
2020
Q4 		$26.2M Buy
728,734
+56,747
+8% +$2.05M 2.58% 7
2020
Q3 		$25.7M Sell
671,987
-339,338
-34% -$13.1M 1.43% 24
2020
Q2 		$35.5M Buy
1,011,325
+92,388
+10% +$3.33M 2.34% 11
2020
Q1 		$30M Buy
+918,937
New +$35.9M 1.78% 18

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

York Capital Management Global Advisors's BSX Position: Q1 2021 in Review

York Capital Management Global Advisors sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 728,734 shares — an estimated $26.2M sold.

York Capital Management Global Advisors first reported a position in BSX in Q1 2020 and held it in 4 quarters. The position peaked at $35.5M in Q2 2020. 830 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • York Capital Management Global Advisors reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • York Capital Management Global Advisors sold 728,734 Boston Scientific shares in Q1 2021, an estimated $26.2M.
  • York Capital Management Global Advisors first reported a position in Boston Scientific in Q1 2020 and held it in 4 quarters.
  • York Capital Management Global Advisors's Boston Scientific position peaked at $35.5M in Q2 2020.
  • 830 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on York Capital Management Global Advisors's 13F filing for Q1 2021, filed 17 May 2021.